1. For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of U.S. patent application Ser. No. 10/827,572, entitled A SYSTEM WITH A RESERVOIR FOR PERFUSION MANAGEMENT, naming Lowell L. Wood, Jr. as inventor, filed 19 Apr. 2004, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
2. For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of U.S. patent application Ser. No. 10/827,578, entitled A SYSTEM WITH A SENSOR FOR PERFUSION MANAGEMENT, naming Lowell L. Wood, Jr. as inventor, filed 19 Apr. 2004, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
3. For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of U.S. patent application Ser. No. 10/827,390, entitled A TELESCOPING PERFUSION MANAGEMENT SYSTEM, naming Lowell L. Wood, Jr. as inventor, filed 19 Apr. 2004, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
The United States Patent Office (USPTO) has published a notice to the effect that the USPTO's computer programs require that patent applicants reference both a serial number and indicate whether an application is a continuation or continuation-in-part. Stephen G Kunin, Benefit of Prior-Filed Application, USPTO Official Gazette Mar. 18, 2003. The present Applicant Entity (hereinafter “Applicant”) has provided above a specific reference to the application(s) from which priority is being claimed as recited by statute. Applicant understands that the statute is unambiguous in its specific reference language and does not require either a serial number or any characterization, such as “continuation” or “continuation-in-part,” for claiming priority to U.S. patent applications. Notwithstanding the foregoing, Applicant understands that the USPTO's computer programs have certain data entry requirements, and hence Applicant is designating the present application as a continuation-in-part of its parent applications as set forth above, but expressly points out that such designations are not to be construed in any way as any type of commentary and/or admission as to whether or not the present application contains any new matter in addition to the matter of its parent application(s).
All subject matter of the Related Applications and of any and all parent, grandparent, great-grandparent, etc. applications of the Related Applications is incorporated herein by reference to the extent such subject matter is not inconsistent herewith.
The present application relates, in general, to detection and/or treatment.
In one aspect, a system includes, but is not limited to at least one arm; a control circuit coupled to said at least one arm; at least one receptacle coupled to said at least one arm; and at least one sensor coupled to said at least one arm, said system configured for implantation in an animal. In addition to the foregoing, other system aspects are described in the claims, drawings, and text forming a part of the present application.
In one aspect, a method includes but is not limited to: making a device, by providing a cavity for storing a receivable; and including at least one transmitting channel coupled to said cavity for delivering said receivable from said cavity to a predetermined location in an animal, cooperative with a monitoring system and a detecting system including logic or software operative for delivering said receivable. In addition to the foregoing, other method aspects are described in the claims, drawings, and text forming a part of the present application.
In another aspect, a method includes but is not limited to: placing a device comprising a receiving unit for storing a deliverable and in communication with a pliable duct; directing said pliable duct to a location; and administering said deliverable from said receiving unit to said location cooperative with a guiding system and a detecting system. In addition to the foregoing, other method aspects are described in the claims, drawings, and text forming a part of the present application.
In one or more various aspects, related systems include but are not limited to circuitry and/or programming for effecting the herein-referenced method aspects; the circuitry and/or programming can be virtually any combination of hardware, software, and/or firmware configured to effect the herein-referenced method aspects depending upon the design choices of the system designer.
In addition to the foregoing, various other method and or system aspects are set forth and described in the text (e.g., claims and/or detailed description) and/or drawings of the present application.
The foregoing is a summary and thus contains, by necessity; simplifications, generalizations and omissions of detail; consequently, those skilled in the art will appreciate that the summary is illustrative only and is NOT intended to be in any way limiting. Other aspects, inventive features, and advantages of the devices and/or processes described herein, as defined solely by the claims, will become apparent in the non-limiting detailed description set forth herein.
The use of the same symbols in different drawings typically indicates similar or identical items.
The present application uses formal outline headings for clarity of presentation. However, it is to be understood that the outline headings are for presentation purposes, and that different types of subject matter may be discussed throughout the application (e.g., device(s)/structure(s) may be described under the process(es)/operations heading(s) and/or process(es)/operations may be discussed under structure(s)/process(es) headings). Hence, the use of the formal outline headings is not intended to be in any way limiting.
1. Perfusion Management Device(s) and/or Process(es).
With reference now to
A. Structure(s) and or Device(s)
With reference to the figures, and with reference now to
A control circuit 110 provides a control signal that may open or close the control valve 108. The control circuit 110 may be connected to a sense line 112 that allows it to monitor the fluid levels within the receptacle 106. Additionally, a sense line 114 connects the control circuit 110 to a sensor 116 at the distal end of the at least one arm 104.
Referring now to
In one aspect one or more fluids are delivered to one or more of selected locations by the device for perfusion management 100. The selected location may be, for example, in proximity to or within a tumor, a circulatory system, an aorta, a vena cava, a site of therapy, or a site of investigation in an animal.
Continuing to refer to
With reference now to
Continuing to refer to
Continuing to refer to
Continuing to refer to
With reference now to
Continuing to refer to
Continuing to refer to
With reference now to
It will also be appreciated by those having skill in the art that the device for perfusion management 100 and its components, such as, for example, the arm 104, the plurality of extended parts 304, or one or more operative tools 324, has a size, dimension, shape, material, and properties of flexion, retraction, and extension to allow for the steering, guiding, or positioning of the components of the device for perfusion management 100. For example, the arm 104 may need to be steered around an occlusion or a fork in the vasculature. In this example, the arm 104 may need to retracted, repositioned and then extended in a new direction. Extending, retracting or repositioning of the arm 104 may be accomplished by techniques known in the art, for example, by using a guide wire or a by employing a shape polymer. In another aspect, the arm may be retracted and then “punched through” an occlusion to dislodge, penetrate, or grapple it. In this example, a laser beam, a shearing tool, a cutting tool, or a drug, for example, a lytic drug, may be employed to degrade or reduce the occlusion. In this example, subsequent to the dislodgement and degradation of the occlusion, the siphon 326 or an evacuation device is employed to evacuate any debris, before the arm 104 continues traveling the circulatory system. It will also be appreciated by those skilled in the art that the device for perfusion management 100 is not restricted to traveling the circulatory system but may be implanted in any tissue, such as, for example, nerve, epithelial, dermal, sub-dermal, connective, or muscle tissue. Additionally, the device for perfusion management 100 may be implanted in inter-tissue spaces, or inter-organ spaces, for example, those found within a body cavity.
In one aspect the device for perfusion management 100 includes an array of sensors 116 positioned across the plurality of extended parts 304 for monitoring, tracking, or mapping a gradient of temperature, pressure, flow, or material concentration in one or more locations. The one or more locations may be, for example, a tissue, an artery, or a vein. In another aspect the device for perfusion management 100 has an auto-correct feature for correcting a sub-normal or abnormal gradient of temperature, pressure, flow, or material concentration. In yet another aspect the device for perfusion management 100 has an auto-correct feature for detecting and correcting a sub-normal or abnormal gradient of temperature, pressure, flow, or material concentration.
The device for perfusion management 100 may be composed of materials known in the art, for example, a metal, a ceramic, a glass, a plastic, a polymer, a biologically compatible material, or a combination. For example, the device for perfusion management 100 may be made of helically-coiled stainless steel wire and coated with a polymer, such as, Teflon™. In another example, the device for perfusion management 100 may be made of helically-coiled stainless steel wire and coated with a polymer and impregnated with one or more of a biological material, for example, including but not limited to, anti coagulants, or inhibitors.
B. Operation(s) and/or Process(es)
Those having skill in the art will appreciate that some or all of the components of the device for perfusion management 100 may be present ex vivo. In one implementation, the device for perfusion management 100 is placed in proximity to the location on the animal, for example, the human body 501, and the at least one arm 104 directed to the selected location and an effective agent delivered in proximity to the selected location. The arm 104 may be retracted after such a delivery, leaving the device for perfusion management 100 in place at the location, until time for a future delivery of the effective agent or another procedure or operation. In this implementation, the majority of the device for perfusion management 100 is ex vivo while the arm 104 alternates between ex vivo and in vivo states.
In another aspect, some or all the components of the device for perfusion management 100 are present in vivo. In one implementation, the device for perfusion management 100 is placed in proximity to the location within the animal, for example, the human body 501, and the arm 104 directed to a selected location and an effective agent delivered in proximity to the selected location. The arm 104 may be retracted after such a delivery, leaving the device for perfusion management 100 in place at the location, until time for a future delivery or another operation. In this implementation, the majority of the device for perfusion management 100 is in vivo while the arm 104 alternates between retracted, partially retracted or unretracted states.
In one implementation, the device for perfusion management 100 is operable by a person. The person monitors, guides, positions, and performs other actions/operations or manages a response consistent with the device for perfusion management 100 being managed by the person. In such an implementation a separate display device can present imagery to aid the person. The imagery may be captured as described above with reference to
C. Variation(s), and/or Implementation(s)
Those having skill in the art will recognize that the present application teaches modifications of the devices, structures, and/or processes within the spirit of the teaching herein. For example, the device for perfusion management 100 need not be limited to managing perfusion. The device provides a mechanism for exploring one or more regions and/or reaching a location within an animal, obtaining information, communicating this information, performing operations, performing procedures, or providing treatment. The treatment includes but is not limited to, for example, treatment of a subnormal, abnormal or pathological condition. In another example, the device for perfusion management 100 may find utility in the management of physiological functions, the detection or elimination of pathological functions or conditions, and/or treatment of a disease or a pathological state of non-human animals. Other modifications of the subject matter herein will be appreciated by one of skill in the art in light of the teachings herein.
The foregoing described aspects depict different components contained within, or connected with, different other components. It is to be understood that such depicted architectures are merely exemplary, and that in fact many other architectures can be implemented which achieve the same functionality. In a conceptual sense, any arrangement of components to achieve the same functionality is effectively “associated” such that the desired functionality is achieved. Hence, any two components herein combined to achieve a particular functionality can be seen as “associated with” each other such that the desired functionality is achieved, irrespective of architectures or intermedial components. Likewise, any two components so associated can also be viewed as being “operably connected”, or “operably coupled”, to each other to achieve the desired functionality.
While particular aspects of the present subject matter described herein have been shown and described, it will be obvious to those skilled in the art that, based upon the teachings herein, changes and modifications may be made without departing from this subject matter described herein and its broader aspects and, therefore, the appended claims are to encompass within their scope all such changes and modifications as are within the true spirit and scope of this subject matter described herein. Furthermore, it is to be understood that the invention is defined solely by the appended claims. It will be understood by those within the art that, in general, terms used herein, and especially in the appended claims (e.g., bodies of the appended claims) are generally intended as “open” terms (e.g., the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” etc.). It will be further understood by those within the art that if a specific number of an introduced claim recitation is intended, such an intent will be explicitly recited in the claim, and in the absence of such recitation no such intent is present. For example, as an aid to understanding, the following appended claims may contain usage of the introductory phrases “at least one” and “one or more” to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles “a” or “an” limits any particular claim containing such introduced claim recitation to inventions containing only one such recitation, even when the same claim includes the introductory phrases “one or more” or “at least one” and indefinite articles such as “a” or “an” (e.g., “a” and/or “an” should typically be interpreted to mean “at least one” or “one or more”); the same holds true for the use of definite articles used to introduce claim recitations. In addition, even if a specific number of an introduced claim recitation is explicitly recited, those skilled in the art will recognize that such recitation should typically be interpreted to mean at least the recited number (e.g., the bare recitation of “two recitations,” without other modifiers, typically means at least two recitations, or two or more recitations), etc.
The present application is related to, claims the earliest available effective filing date(s) from the following listed application(s) (the “Related Applications”) (e.g., claims earliest available priority dates for other than provisional patent applications or claims benefits under 35 USC § 119(e) for provisional patent applications), and incorporates by reference in its entirety all subject matter of the following listed applications(s) to the extent such subject matter is not inconsistent herewith; the present application also claims the earliest available effective filing date(s) from, and also incorporates by reference in its entirety all subject matter of any and all parent, grandparent, great-grandparent, etc. applications of the “Related Application(s).”
Number | Name | Date | Kind |
---|---|---|---|
3391697 | Greatbatch | Jul 1968 | A |
3821469 | Whetstone et al. | Jun 1974 | A |
3837339 | Aisenberg et al. | Sep 1974 | A |
3941127 | Froning | Mar 1976 | A |
3983474 | Kuipers | Sep 1976 | A |
4054881 | Raab | Oct 1977 | A |
4119900 | Kremnitz | Oct 1978 | A |
4202349 | Jones | May 1980 | A |
4262306 | Renner | Apr 1981 | A |
4267831 | Aguilar | May 1981 | A |
4314251 | Raab | Feb 1982 | A |
4317078 | Weed et al. | Feb 1982 | A |
4339953 | Iwasaki | Jul 1982 | A |
4367741 | Michaels | Jan 1983 | A |
4396885 | Constant | Aug 1983 | A |
4403321 | Krüger | Sep 1983 | A |
4418422 | Richter et al. | Nov 1983 | A |
4431005 | McCormick | Feb 1984 | A |
4583190 | Salb | Apr 1986 | A |
4585652 | Miller et al. | Apr 1986 | A |
4628928 | Lowell | Dec 1986 | A |
4638798 | Shelden et al. | Jan 1987 | A |
4642786 | Hansen | Feb 1987 | A |
4651732 | Frederick | Mar 1987 | A |
4658214 | Petersen | Apr 1987 | A |
4714460 | Calderon | Dec 1987 | A |
4717381 | Papantonakos | Jan 1988 | A |
4733661 | Palestrant | Mar 1988 | A |
4750488 | Wuchinich et al. | Jun 1988 | A |
4763667 | Manzo | Aug 1988 | A |
4769006 | Papantonakos | Sep 1988 | A |
4771772 | DeWitt | Sep 1988 | A |
4795434 | Kujawski | Jan 1989 | A |
4800898 | Hess et al. | Jan 1989 | A |
4805615 | Carol | Feb 1989 | A |
4817601 | Roth et al. | Apr 1989 | A |
4871351 | Feingold | Oct 1989 | A |
4889526 | Rauscher et al. | Dec 1989 | A |
4905689 | Stack et al. | Mar 1990 | A |
4943296 | Funakubo et al. | Jul 1990 | A |
4944659 | Labbe et al. | Jul 1990 | A |
4962453 | Pong et al. | Oct 1990 | A |
4994071 | MacGregor | Feb 1991 | A |
5019372 | Folkman et al. | May 1991 | A |
5031109 | Gloton | Jul 1991 | A |
5051906 | Evans, Jr. et al. | Sep 1991 | A |
5078140 | Kwoh | Jan 1992 | A |
5086401 | Glassman et al. | Feb 1992 | A |
5153827 | Coutre et al. | Oct 1992 | A |
5165064 | Mattaboni | Nov 1992 | A |
5176638 | Don Michael | Jan 1993 | A |
5188111 | Yates et al. | Feb 1993 | A |
5204814 | Noonan et al. | Apr 1993 | A |
5234457 | Andersen | Aug 1993 | A |
5269303 | Wernicke et al. | Dec 1993 | A |
5279607 | Schentag et al. | Jan 1994 | A |
5310404 | Gyory et al. | May 1994 | A |
5313835 | Dunn | May 1994 | A |
5314451 | Mulier | May 1994 | A |
5321614 | Ashworth | Jun 1994 | A |
5335657 | Terry, Jr. et al. | Aug 1994 | A |
5337732 | Grundfest et al. | Aug 1994 | A |
5338625 | Bates et al. | Aug 1994 | A |
5339051 | Koehler et al. | Aug 1994 | A |
5353807 | DeMarco | Oct 1994 | A |
5374285 | Vaiani et al. | Dec 1994 | A |
5381786 | Spears | Jan 1995 | A |
5386741 | Rennex | Feb 1995 | A |
5395390 | Simon et al. | Mar 1995 | A |
5398670 | Ortiz et al. | Mar 1995 | A |
5403311 | Abele et al. | Apr 1995 | A |
5411551 | Winston et al. | May 1995 | A |
5437660 | Johnson et al. | Aug 1995 | A |
5476450 | Ruggio | Dec 1995 | A |
5497147 | Arms et al. | Mar 1996 | A |
5502638 | Takenaka | Mar 1996 | A |
5507287 | Palcic et al. | Apr 1996 | A |
5522394 | Zurbrugg | Jun 1996 | A |
5551953 | Lattin et al. | Sep 1996 | A |
5554914 | Miyazawa | Sep 1996 | A |
5569968 | Lal et al. | Oct 1996 | A |
5574347 | Neubauer | Nov 1996 | A |
5589932 | Garcia-Rubio et al. | Dec 1996 | A |
5593434 | Williams | Jan 1997 | A |
5599324 | McAlister et al. | Feb 1997 | A |
5610488 | Miyazawa | Mar 1997 | A |
5624398 | Smith et al. | Apr 1997 | A |
5632754 | Farley et al. | May 1997 | A |
5643296 | Hundertmark et al. | Jul 1997 | A |
5662587 | Grundfest et al. | Sep 1997 | A |
5669874 | Feiring | Sep 1997 | A |
5670329 | Oberhardt | Sep 1997 | A |
5674276 | Andersen et al. | Oct 1997 | A |
5688269 | Newton et al. | Nov 1997 | A |
5695457 | St. Goar et al. | Dec 1997 | A |
5697967 | Dinh et al. | Dec 1997 | A |
5702432 | Chen et al. | Dec 1997 | A |
5705293 | Hobson | Jan 1998 | A |
5728089 | Lal et al. | Mar 1998 | A |
5735276 | Lemelson | Apr 1998 | A |
5737279 | Carter | Apr 1998 | A |
5758298 | Guldner | May 1998 | A |
5782798 | Rise | Jul 1998 | A |
5804563 | Still et al. | Sep 1998 | A |
5807395 | Mulier et al. | Sep 1998 | A |
5819736 | Avny et al. | Oct 1998 | A |
5827190 | Palcic et al. | Oct 1998 | A |
5830179 | Mikus et al. | Nov 1998 | A |
5830207 | Leeb et al. | Nov 1998 | A |
5831012 | Nilsson et al. | Nov 1998 | A |
5833603 | Kovacs et al. | Nov 1998 | A |
5843139 | Goedeke et al. | Dec 1998 | A |
5855801 | Lin et al. | Jan 1999 | A |
5865754 | Sevick-Muraca et al. | Feb 1999 | A |
5873835 | Hastings et al. | Feb 1999 | A |
5908027 | Butterfield et al. | Jun 1999 | A |
5921982 | Lesh et al. | Jul 1999 | A |
5947119 | Reznick | Sep 1999 | A |
5951600 | Lemelson | Sep 1999 | A |
5954675 | Dellagatta | Sep 1999 | A |
5964773 | Greenstein | Oct 1999 | A |
6004269 | Crowley et al. | Dec 1999 | A |
6016449 | Fischell et al. | Jan 2000 | A |
6019729 | Itoigawa et al. | Feb 2000 | A |
6022316 | Eppstein et al. | Feb 2000 | A |
6053873 | Govari et al. | Apr 2000 | A |
6086528 | Adair | Jul 2000 | A |
6102845 | Woodard et al. | Aug 2000 | A |
6108597 | Kirchner et al. | Aug 2000 | A |
6111520 | Allen et al. | Aug 2000 | A |
6128538 | Fischell et al. | Oct 2000 | A |
6134474 | Fischell et al. | Oct 2000 | A |
6149603 | Parker | Nov 2000 | A |
6159230 | Samuels | Dec 2000 | A |
6164284 | Schulman et al. | Dec 2000 | A |
6170488 | Spillman, Jr. et al. | Jan 2001 | B1 |
6175757 | Watkins et al. | Jan 2001 | B1 |
6179789 | Tu et al. | Jan 2001 | B1 |
6185452 | Schulman et al. | Feb 2001 | B1 |
6186986 | Berg et al. | Feb 2001 | B1 |
6187599 | Asher et al. | Feb 2001 | B1 |
6197013 | Reed et al. | Mar 2001 | B1 |
6219577 | Brown, III et al. | Apr 2001 | B1 |
6221099 | Andersen et al. | Apr 2001 | B1 |
6240312 | Alfano et al. | May 2001 | B1 |
6240316 | Richmond et al. | May 2001 | B1 |
6248345 | Goldenheim et al. | Jun 2001 | B1 |
6249076 | Madden et al. | Jun 2001 | B1 |
6255361 | Rajagopalan et al. | Jul 2001 | B1 |
6255793 | Peless et al. | Jul 2001 | B1 |
6263245 | Snell | Jul 2001 | B1 |
6278379 | Allen et al. | Aug 2001 | B1 |
6280386 | Alfano et al. | Aug 2001 | B1 |
6289270 | Baumgarten | Sep 2001 | B1 |
6295990 | Lewis et al. | Oct 2001 | B1 |
6296638 | Davison et al. | Oct 2001 | B1 |
6322532 | D'Sa et al. | Nov 2001 | B1 |
6337997 | Rise | Jan 2002 | B1 |
6372248 | Qin et al. | Apr 2002 | B1 |
6383162 | Sugarbaker | May 2002 | B1 |
6384741 | O'Leary, Sr. | May 2002 | B1 |
6385472 | Hall et al. | May 2002 | B1 |
6398280 | Parker et al. | Jun 2002 | B1 |
6400980 | Lemelson | Jun 2002 | B1 |
6402678 | Fischell et al. | Jun 2002 | B1 |
6409674 | Brockway et al. | Jun 2002 | B1 |
6417641 | Peless et al. | Jul 2002 | B2 |
6431171 | Burton | Aug 2002 | B1 |
6436120 | Meglin | Aug 2002 | B1 |
6442413 | Silver | Aug 2002 | B1 |
6450937 | Mercereau et al. | Sep 2002 | B1 |
6453199 | Kobozev | Sep 2002 | B1 |
6464687 | Ishikawa et al. | Oct 2002 | B1 |
6475639 | Shahinpoor et al. | Nov 2002 | B2 |
6490483 | Willis | Dec 2002 | B2 |
6491618 | Ganz | Dec 2002 | B1 |
6493607 | Bourne et al. | Dec 2002 | B1 |
6497714 | Ishikawa et al. | Dec 2002 | B1 |
6500174 | Maguire et al. | Dec 2002 | B1 |
6512949 | Combs et al. | Jan 2003 | B1 |
6512950 | Li et al. | Jan 2003 | B2 |
6514237 | Maseda | Feb 2003 | B1 |
6530950 | Alvarado et al. | Mar 2003 | B1 |
6547723 | Ouchi | Apr 2003 | B1 |
6547825 | Shimizu et al. | Apr 2003 | B1 |
6548982 | Papanikolopoulos et al. | Apr 2003 | B1 |
6554798 | Mann et al. | Apr 2003 | B1 |
6575969 | Rittman, III et al. | Jun 2003 | B1 |
6585763 | Keilman et al. | Jul 2003 | B1 |
6591137 | Fischell et al. | Jul 2003 | B1 |
6592567 | Levin et al. | Jul 2003 | B1 |
6597954 | Pless et al. | Jul 2003 | B1 |
6607553 | Healy et al. | Aug 2003 | B1 |
6612982 | Ouchi | Sep 2003 | B1 |
6616676 | Bashiri et al. | Sep 2003 | B2 |
6623519 | Edwin et al. | Sep 2003 | B2 |
6632216 | Houzego et al. | Oct 2003 | B2 |
6638273 | Farley et al. | Oct 2003 | B1 |
6648908 | Dobak, III et al. | Nov 2003 | B2 |
6666860 | Takahashi | Dec 2003 | B1 |
6669683 | Santini, Jr. et al. | Dec 2003 | B2 |
6673042 | Samson et al. | Jan 2004 | B1 |
6673363 | Luo et al. | Jan 2004 | B2 |
6679893 | Tran | Jan 2004 | B1 |
6709388 | Mosse et al. | Mar 2004 | B1 |
6711423 | Colvin, Jr. | Mar 2004 | B2 |
6712835 | Mazzocchi et al. | Mar 2004 | B2 |
6719684 | Kim et al. | Apr 2004 | B2 |
6723092 | Brown et al. | Apr 2004 | B2 |
6733485 | Whitehurst et al. | May 2004 | B1 |
6735474 | Loeb et al. | May 2004 | B1 |
6735475 | Whitehurst et al. | May 2004 | B1 |
6743211 | Prausnitz et al. | Jun 2004 | B1 |
6754536 | Swoyer et al. | Jun 2004 | B2 |
6755802 | Bell | Jun 2004 | B2 |
6755803 | Le et al. | Jun 2004 | B1 |
6764441 | Chiel et al. | Jul 2004 | B2 |
6770071 | Woloszko et al. | Aug 2004 | B2 |
6773429 | Sheppard, Jr. et al. | Aug 2004 | B2 |
6776165 | Jin | Aug 2004 | B2 |
6797522 | Still et al. | Sep 2004 | B1 |
6802811 | Slepian | Oct 2004 | B1 |
6816632 | Slice | Nov 2004 | B1 |
6824508 | Kim et al. | Nov 2004 | B2 |
6824510 | Kim et al. | Nov 2004 | B2 |
6824561 | Soykan et al. | Nov 2004 | B2 |
6834118 | Kim | Dec 2004 | B2 |
6849183 | Gorsuch et al. | Feb 2005 | B2 |
6855115 | Fonseca et al. | Feb 2005 | B2 |
6860867 | Seward et al. | Mar 2005 | B2 |
6861001 | Lee et al. | Mar 2005 | B2 |
6866626 | Long et al. | Mar 2005 | B2 |
6869430 | Balbierz et al. | Mar 2005 | B2 |
6875209 | Zvuloni et al. | Apr 2005 | B2 |
6882881 | Lesser et al. | Apr 2005 | B1 |
6889091 | Hine et al. | May 2005 | B2 |
6890303 | Fitz | May 2005 | B2 |
6898464 | Edell et al. | May 2005 | B2 |
6911004 | Kim et al. | Jun 2005 | B2 |
6911496 | Rhee et al. | Jun 2005 | B2 |
6920359 | Meadows et al. | Jul 2005 | B2 |
6921413 | Mahadevan-Jansen et al. | Jul 2005 | B2 |
6925357 | Wang et al. | Aug 2005 | B2 |
6929636 | Von Alten | Aug 2005 | B1 |
6936003 | Iddan | Aug 2005 | B2 |
6939290 | Iddan | Sep 2005 | B2 |
6939376 | Shulze et al. | Sep 2005 | B2 |
6950707 | Whitehurst | Sep 2005 | B2 |
6953589 | Trautman et al. | Oct 2005 | B1 |
6958034 | Iddan | Oct 2005 | B2 |
6959215 | Gliner et al. | Oct 2005 | B2 |
6960227 | Jones et al. | Nov 2005 | B2 |
6963792 | Green | Nov 2005 | B1 |
6984205 | Gazdzinski | Jan 2006 | B2 |
6984952 | Peless et al. | Jan 2006 | B2 |
6991617 | Hektner et al. | Jan 2006 | B2 |
7003352 | Whitehurst | Feb 2006 | B1 |
7013177 | Whitehurst et al. | Mar 2006 | B1 |
7020231 | Frey et al. | Mar 2006 | B1 |
7027134 | Garcia-Rubio et al. | Apr 2006 | B1 |
7037343 | Imran | May 2006 | B2 |
7039453 | Mullick et al. | May 2006 | B2 |
7042184 | Oleynikov et al. | May 2006 | B2 |
7044911 | Drinan et al. | May 2006 | B2 |
RE39133 | Clayton et al. | Jun 2006 | E |
7066180 | Aylsworth et al. | Jun 2006 | B2 |
7083578 | Lewkowicz et al. | Aug 2006 | B2 |
7101386 | Dobak, III | Sep 2006 | B2 |
7115109 | Gerdts et al. | Oct 2006 | B2 |
7118531 | Krill | Oct 2006 | B2 |
7125382 | Zhou et al. | Oct 2006 | B2 |
7131979 | DiCarlo et al. | Nov 2006 | B2 |
7160258 | Imran et al. | Jan 2007 | B2 |
7171285 | Kim et al. | Jan 2007 | B2 |
7181261 | Silver et al. | Feb 2007 | B2 |
7195641 | Palmaz et al. | Mar 2007 | B2 |
7212110 | Martin et | May 2007 | B1 |
7214182 | Shimizu et al. | May 2007 | B2 |
7228162 | Ward et al. | Jun 2007 | B2 |
7236821 | Cates et al. | Jun 2007 | B2 |
7245954 | Glukhovsky | Jul 2007 | B2 |
7297113 | Russell et al. | Nov 2007 | B1 |
7341577 | Gill | Mar 2008 | B2 |
7365509 | Park et al. | Apr 2008 | B2 |
7365614 | McCorquodale et al. | Apr 2008 | B2 |
7383071 | Russell et al. | Jun 2008 | B1 |
7398734 | Jean | Jul 2008 | B1 |
7451537 | Liu et al. | Nov 2008 | B2 |
7486967 | Pan et al. | Feb 2009 | B2 |
7572228 | Wolinsky et al. | Aug 2009 | B2 |
7596403 | Horn | Sep 2009 | B2 |
7625338 | Gilad et al. | Dec 2009 | B2 |
7684840 | Palti | Mar 2010 | B2 |
7713196 | Baker, Jr. | May 2010 | B2 |
7736300 | Ziegler et al. | Jun 2010 | B2 |
7744542 | Piaget et al. | Jun 2010 | B2 |
7801626 | Moser | Sep 2010 | B2 |
7840271 | Kieval et al. | Nov 2010 | B2 |
7857767 | Ferren et al. | Dec 2010 | B2 |
20010029348 | Willis | Oct 2001 | A1 |
20010051766 | Gazdzinski | Dec 2001 | A1 |
20020026188 | Balbierz et al. | Feb 2002 | A1 |
20020065509 | Lebel et al. | May 2002 | A1 |
20020068080 | Lerner | Jun 2002 | A1 |
20020090388 | Humes et al. | Jul 2002 | A1 |
20020103417 | Gazdzinski | Aug 2002 | A1 |
20020116029 | Miller et al. | Aug 2002 | A1 |
20020116034 | Miller et al. | Aug 2002 | A1 |
20020120263 | Brown et al. | Aug 2002 | A1 |
20020147480 | Mamayek | Oct 2002 | A1 |
20020156462 | Stultz | Oct 2002 | A1 |
20020165592 | Glukhovsky et al. | Nov 2002 | A1 |
20020169436 | Gurm et al. | Nov 2002 | A1 |
20020171385 | Kim et al. | Nov 2002 | A1 |
20020183721 | Santini, Jr. et al. | Dec 2002 | A1 |
20020188323 | Penner et al. | Dec 2002 | A1 |
20020193679 | Malave et al. | Dec 2002 | A1 |
20020193874 | Crowley | Dec 2002 | A1 |
20020198470 | Imran et al. | Dec 2002 | A1 |
20020198521 | Maguire | Dec 2002 | A1 |
20020198604 | Schulman et al. | Dec 2002 | A1 |
20030004403 | Drinan et al. | Jan 2003 | A1 |
20030023150 | Yokoi et al. | Jan 2003 | A1 |
20030024534 | Silvestri et al. | Feb 2003 | A1 |
20030040704 | Dorros et al. | Feb 2003 | A1 |
20030060723 | Joo et al. | Mar 2003 | A1 |
20030065250 | Chiel et al. | Apr 2003 | A1 |
20030065358 | Frecker et al. | Apr 2003 | A1 |
20030069475 | Banik et al. | Apr 2003 | A1 |
20030069523 | Williams et al. | Apr 2003 | A1 |
20030093031 | Long et al. | May 2003 | A1 |
20030151524 | Clark | Aug 2003 | A1 |
20030152823 | Heller | Aug 2003 | A1 |
20030153866 | Long et al. | Aug 2003 | A1 |
20030158584 | Cates et al. | Aug 2003 | A1 |
20030163177 | Eggers et al. | Aug 2003 | A1 |
20030167000 | Mullick et al. | Sep 2003 | A1 |
20030191430 | D'Andrea et al. | Oct 2003 | A1 |
20030214579 | Iddan | Nov 2003 | A1 |
20030214580 | Iddan | Nov 2003 | A1 |
20030220556 | Porat et al. | Nov 2003 | A1 |
20040008853 | Pelrine et al. | Jan 2004 | A1 |
20040018508 | Friedman | Jan 2004 | A1 |
20040019374 | Hojeibane et al. | Jan 2004 | A1 |
20040034332 | Uhland | Feb 2004 | A1 |
20040064093 | Hektner et al. | Apr 2004 | A1 |
20040073177 | Hickle | Apr 2004 | A1 |
20040073190 | Deem et al. | Apr 2004 | A1 |
20040092825 | Madar et al. | May 2004 | A1 |
20040097805 | Verard et al. | May 2004 | A1 |
20040097819 | Duarte | May 2004 | A1 |
20040098030 | Makower et al. | May 2004 | A1 |
20040111019 | Long | Jun 2004 | A1 |
20040133147 | Woo | Jul 2004 | A1 |
20040138517 | Osorio et al. | Jul 2004 | A1 |
20040147939 | Rabkin et al. | Jul 2004 | A1 |
20040148034 | Kagan et al. | Jul 2004 | A1 |
20040152988 | Weirich | Aug 2004 | A1 |
20040162469 | Imran | Aug 2004 | A1 |
20040162501 | Imran | Aug 2004 | A1 |
20040176664 | Iddan | Sep 2004 | A1 |
20040193010 | Fujimori et al. | Sep 2004 | A1 |
20040199246 | Chu et al. | Oct 2004 | A1 |
20040225325 | Bonutti | Nov 2004 | A1 |
20040225326 | Weiner et al. | Nov 2004 | A1 |
20040260391 | Santini, Jr. et al. | Dec 2004 | A1 |
20040267240 | Gross et al. | Dec 2004 | A1 |
20050004474 | Iddan | Jan 2005 | A1 |
20050004553 | Douk | Jan 2005 | A1 |
20050021023 | Guglielmi et al. | Jan 2005 | A1 |
20050027236 | Douk | Feb 2005 | A1 |
20050043583 | Killmann et al. | Feb 2005 | A1 |
20050058701 | Gross et al. | Mar 2005 | A1 |
20050062562 | Ries | Mar 2005 | A1 |
20050065592 | Holzer | Mar 2005 | A1 |
20050069925 | Ford et al. | Mar 2005 | A1 |
20050079132 | Wang et al. | Apr 2005 | A1 |
20050107870 | Wang et al. | May 2005 | A1 |
20050113460 | Glick | May 2005 | A1 |
20050121411 | Cohen | Jun 2005 | A1 |
20050126916 | Lockard et al. | Jun 2005 | A1 |
20050149170 | Van Tassel et al. | Jul 2005 | A1 |
20050151524 | Sae-Ueng et al. | Jul 2005 | A1 |
20050171418 | Lin | Aug 2005 | A1 |
20050171434 | Madden et al. | Aug 2005 | A1 |
20050177223 | Palmaz | Aug 2005 | A1 |
20050182482 | Wang et al. | Aug 2005 | A1 |
20050203613 | Arney et al. | Sep 2005 | A1 |
20050215911 | Alfano et al. | Sep 2005 | A1 |
20050216074 | Sahatjian et al. | Sep 2005 | A1 |
20050221529 | Bang et al. | Oct 2005 | A1 |
20050228259 | Glukhovsky et al. | Oct 2005 | A1 |
20050234393 | Wood, Jr. | Oct 2005 | A1 |
20050234440 | Wood, Jr. | Oct 2005 | A1 |
20050238689 | Carpenter et al. | Oct 2005 | A1 |
20050272806 | Falotico et al. | Dec 2005 | A1 |
20050272974 | Iddan | Dec 2005 | A1 |
20050277839 | Alderman et al. | Dec 2005 | A1 |
20050278020 | Wang et al. | Dec 2005 | A1 |
20060004395 | Chiel et al. | Jan 2006 | A1 |
20060009810 | Mann et al. | Jan 2006 | A1 |
20060015146 | Girouard et al. | Jan 2006 | A1 |
20060037617 | Walke et al. | Feb 2006 | A1 |
20060042631 | Martin et al. | Mar 2006 | A1 |
20060074479 | Bailey et al. | Apr 2006 | A1 |
20060119304 | Farritor et al. | Jun 2006 | A1 |
20060152309 | Mintchev et al. | Jul 2006 | A1 |
20060167339 | Gilad et al. | Jul 2006 | A1 |
20060169294 | Kaler et al. | Aug 2006 | A1 |
20060235275 | Rabinovitz et al. | Oct 2006 | A1 |
20060252987 | Hasegawa et al. | Nov 2006 | A1 |
20070010868 | Ferren et al. | Jan 2007 | A1 |
20070066929 | Ferren et al. | Mar 2007 | A1 |
20070088334 | Hillis et al. | Apr 2007 | A1 |
20070156211 | Ferren et al. | Jul 2007 | A1 |
20070225634 | Ferren et al. | Sep 2007 | A1 |
20080063703 | Gross et al. | Mar 2008 | A1 |
20080066929 | Costa et al. | Mar 2008 | A1 |
20080121054 | Goldenberg et al. | May 2008 | A1 |
20080241847 | Hoon et al. | Oct 2008 | A1 |
20080243056 | Hillis et al. | Oct 2008 | A1 |
20080266106 | Lim et al. | Oct 2008 | A1 |
20090062646 | Creighton, IV et al. | Mar 2009 | A1 |
20090069821 | Farritor et al. | Mar 2009 | A1 |
20090082652 | Koh et al. | Mar 2009 | A1 |
20090182388 | Von Arx et al. | Jul 2009 | A1 |
Number | Date | Country |
---|---|---|
9981027.1 | Oct 2001 | CN |
1 245 201 | Oct 2002 | EP |
1 618 831 | Jan 2006 | EP |
2 163 206 | Mar 2010 | EP |
2001-506871 | Mar 1998 | JP |
2002-153569 | May 2002 | JP |
2005-74229 | Mar 2005 | JP |
WO 9639999 | Dec 1996 | WO |
WO 9809582 | Mar 1998 | WO |
WO 9814243 | Apr 1998 | WO |
WO 9920335 | Apr 1999 | WO |
WO 9944665 | Sep 1999 | WO |
WO 0069515 | Nov 2000 | WO |
WO 0108548 | Feb 2001 | WO |
WO 0124731 | Apr 2001 | WO |
WO 03072157 | Sep 2003 | WO |
WO 03090618 | Nov 2003 | WO |
WO 03106966 | Dec 2003 | WO |
WO 2004028335 | Apr 2004 | WO |
WO 2004058041 | Jul 2004 | WO |
WO 2004086958 | Oct 2004 | WO |
WO 2005082248 | Sep 2005 | WO |
Number | Date | Country | |
---|---|---|---|
20050234399 A1 | Oct 2005 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10827572 | Apr 2004 | US |
Child | 10827576 | US | |
Parent | 10827578 | Apr 2004 | US |
Child | 10827572 | US | |
Parent | 10827390 | Apr 2004 | US |
Child | 10827578 | US |